Francisco Vizcarrondo
Hematology & Oncology · Birmingham, ALNPI 1487760328
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,470 of the $38,810 with a category attached, or 75.9%. 7 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 50.6% of the total.
Across 40 payments — averaging $970.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- Merck$8K
- Boehringer Ingelheim$4K
- Genentech USA, Inc.$4K
- Pfizer$2K
- AstraZeneca$685
- plus $11 from 1 others
Across 462 payments — averaging $4637.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$544K
- Merck$385K
- Seagen Inc.$357K
- Incyte Corporation$268K
- Boehringer Ingelheim$189K
- AstraZeneca$107K
- plus $294K from 7 others
What the payments were for
- Consulting fees$3,86910%
- Speaking & faculty fees$29,47076%
- Travel & lodging$4,86013%
- Food & beverage$6112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $19,643 |
| Merck | 9 | $8,375 |
| Boehringer Ingelheim | 4 | $4,127 |
| Genentech USA, Inc. | 8 | $3,789 |
| Pfizer | 2 | $2,180 |
| AstraZeneca | 1 | $685 |
| BD | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,810 in reported general payments places this provider in the 85th percentile of 177 hematology & oncology providers in Alabama.
Other hematology & oncology in Birmingham
- Amitkumar MehtaBirmingham$683K
- Pankit VachhaniBirmingham$545K
- Luciano CostaBirmingham$409K
- Khaleel AshrafBirmingham$379K
- Michael BirrerBirmingham$302K
- Rudolph NavariBirmingham$254K
- Mayur NarkhedeBirmingham$193K
- Midhun MallaBirmingham$144K
- Robert ConryBirmingham$143K
- David MooneyBirmingham$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.